G1 Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to target key components of the DNA damage response pathway. Their innovative approach aims to address the unmet needs of cancer patients by improving outcomes and reducing treatment side effects.
Notification